Navigation Links
KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH
Date:11/7/2013

titute
  • Location: Ernest N. Morial Convention Center, Hall E.
  • Additional Abstracts

    In addition to the abstract accepted for presentation, two additional abstracts describing  EphA3 expression and screening in myeloid malignancies were accepted for publication online and in the ASH conference materials. These abstracts outline An Immunohistochemistry (IHC) Screen For EphA3 Positive Tumors and Analysis of EphA3 Expression in Hematologic Malignancies by Quantitative PCR.

    "These published abstracts further detail our ongoing research efforts on EphA3," stated Dr. Geoffrey Yarranton, Chief Scientific Officer and Executive Vice President of Research and Development at KaloBios. "We continue to work to understand EphA3 expression on various tumor types, and we now have a validated EphA3 screening test operative at a CLIA laboratory to screen patients' tumor biopsies before entry into the Phase 2 portion of Study KB004-01 in AML and MDS."

    About KaloBios

    KaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies designed to treat severe life-threatening or debilitating diseases for which there is an unmet medical need, with a clinical focus on severe respiratory diseases and cancer.

    Currently, KaloBios has three drug development programs:

    • KB003, an anti-GM-CSF mAb with potential to treat inflammatory diseases, being developed for the treatment of severe asthma. Enrollment of 160 patients has been completed in a Phase 2 study in the United States, Europe and Australia.
    • KB001-A, an anti-PcrV mAb fragment that is partnered exclusively with Sanofi Pasteur and is being developed for the prevention and treatment of Pa infections. KaloBios has retained right
      '/>"/>

    SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology news :

    1. Cell therapy using patients own bone marrow may present option for heart disease
    2. Report presents designs for study of cancer risks near US nuclear facilities
    3. Entomology 2012 to present 105 insect symposia in November
    4. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
    5. The Brain Prize 2012 is presented May 9th
    6. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
    7. John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
    8. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
    9. Coral reef experts to present latest coral reef science during July symposium
    10. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
    11. GSA Bulletin presents studies in Antarctica, Italy, Mexico, Algeria, Mongolia, and more
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/5/2014)... his career to understanding the Earth,s climate and ... As deputy director and regional climatologist for the ... Institute, Redmond has more than three decades of ... climate data to the general public. , At ... on December 15-19, 2014 the American Geophysical Union ...
    (Date:11/4/2014)... Fla. (November 4, 2014) — Think about the way ... How do neighboring cells know that they are supposed ... how do these tissues find the correct place and ... answering these crucial questions. , In a new study, ... to communicate with their surrounding neighbors, at the head-trunk ...
    (Date:11/3/2014)... 2014 Research and Markets has announced ... Technologies, Markets and Companies" to their offering. ... methods, which have already started to play an important role ... replacing the old fashioned bone marrow transplants. Role of cells ... to become a part of medical practice. Stem ...
    Breaking Biology News(10 mins):Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2The inside story: How the brain and skull stay together 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
    ... debated the cause of the Plague of Athens. Analysis ... collected from teeth from an ancient Greek burial pit ... this devastating epidemic. The study appears on the online ... published by Elsevier on behalf of the International Society ...
    ... invasive weed that has spread across much of the U.S. ... chemicals harmful to a soil fungus the trees depend on ... Public Library of Science. The tree-stifling alien, garlic mustard (Alliaria ... since spread to Canada and 30 states in the East ...
    ... to screen blood donations in all US states for West Nile ... view, say researchers from Columbia University and Harvard School of Public ... of year to worry about mosquitoes, it seems a good time ... products for WNV, and to ensure that the best policy is ...
    Cached Biology News:Typhoid fever led to the fall of Athens 2Invasive species harms native hardwoods by killing soil fungus 2Invasive species harms native hardwoods by killing soil fungus 3Screening blood for West Nile virus 2
    (Date:11/18/2014)... DOYLESTOWN, Pa. , Nov. 18, 2014  Novira ... therapies for curative treatment of chronic hepatitis B virus ... , M.D., was appointed to its Scientific Advisory Board ... Brian join our SAB," said Christian S. Schade ... wealth of clinical development experience which will be invaluable ...
    (Date:11/16/2014)... 17, 2014 The “Fluid Management ... fluid visualization systems market with an analysis and ... & irrigation, dialyzes, fluid warming and waste management. ... the fluid visualization systems by applications and regions ... market was valued at $19,285.5 million in 2013 ...
    (Date:11/15/2014)... As part of an ongoing ... in its network and logistics capabilities to meet ... the complex requirements of the industry. , The ... logistics and transportation, and includes opening new QuickSTAT ... will be an emphasis on Customer Service capabilities, ...
    (Date:11/15/2014)... 2014 CannLabs, Inc. ... analytics, and scientific testing methodologies relating to cannabis, ... ended September 30, 2014, and provided a business ... ,     CannLabs – Nevada, Inc. granted license for ...     CannLabs – Connecticut, Inc. opened a 4,000-sq.-ft. ...
    Breaking Biology Technology:Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 2Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 3Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 4QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2CannLabs Announces Third Quarter 2014 Results. 2CannLabs Announces Third Quarter 2014 Results. 3CannLabs Announces Third Quarter 2014 Results. 4CannLabs Announces Third Quarter 2014 Results. 5
    ... 20, 2010 ... ... --> ... // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
    ... SAN DIEGO, Oct. 19, 2010 Amylin Pharmaceuticals, Inc. ... net product sales for the quarter ended September 30, ... the quarter include $132.4 million for BYETTA® (exanatide) injection ... compares to net product sales of $192.9 million consisting ...
    ... 19, 2010 -- The Cold Triple Axis spectrometer, a ... Isotope Reactor and a complementary tool to other neutron ... The CTAX uses "cold" neutrons from the HFIR ... Cold neutrons are slower than their "thermal" neutron counterparts, ...
    Cached Biology Technology:JIPH Accepted for MEDLINE Indexing 2JIPH Accepted for MEDLINE Indexing 3JIPH Accepted for MEDLINE Indexing 4JIPH Accepted for MEDLINE Indexing 5JIPH Accepted for MEDLINE Indexing 6JIPH Accepted for MEDLINE Indexing 7JIPH Accepted for MEDLINE Indexing 8JIPH Accepted for MEDLINE Indexing 9ORNL's research reactor revamps veteran neutron scattering tool 2
    ... Immunogen: Synthetic peptide derived from the N-terminal ... ZO-1. Specificity: Specific for the N-terminus ... Reactivity: Human Dog Rat Mouse (positive controls: ... mouse liver heart blood vessel and brain ...
    Human Carnosine Dipeptidase 1 Affinity Purified PAb...
    ... Lauryl Ether 30% concentration ... Preservative. Surfactant. Clear Solution. ... is 1 mL of ... added to 400 mL ...
    Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
    Biology Products: